Why has the epidemiology of RSV changed during the COVID-19 pandemic?

[1]  S. Madhi,et al.  All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020–22) compared with the pre-pandemic period (2015–19) in South Africa: an observational study , 2023, The Lancet. Infectious diseases.

[2]  M. McMorrow,et al.  Seasonality of Respiratory Syncytial Virus — United States, 2017–2023 , 2023, MMWR. Morbidity and mortality weekly report.

[3]  E. Liu,et al.  Epidemiological characteristics of respiratory viruses in hospitalized children during the COVID-19 pandemic in southwestern China , 2023, Frontiers in Cellular and Infection Microbiology.

[4]  A. Greninger,et al.  Genomic Characterization of Respiratory Syncytial Virus during 2022–23 Outbreak, Washington, USA , 2023, Emerging infectious diseases.

[5]  M. Wolfe,et al.  Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study , 2023, The Lancet Microbe.

[6]  Katherine C DeRuff,et al.  RSV Surge in the USA and Viral Lineages, 2022 , 2023, The New England journal of medicine.

[7]  M. Redlberger-Fritz,et al.  The respiratory syncytial virus surge in Austria, 2022, was caused by lineages present before the COVID-19 pandemic , 2023, bioRxiv.

[8]  R. Lynfield,et al.  Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19. , 2023, Pediatrics.

[9]  Po-Yu Liu,et al.  The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review , 2023, Infection and drug resistance.

[10]  U. Nygaard,et al.  Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID-19 pandemic: a Danish nationwide cohort study , 2023, The Lancet Child & Adolescent Health.

[11]  P. Murcia,et al.  Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract , 2022, The Journal of infectious diseases.

[12]  R. V. Van BInnendijk,et al.  Decline of RSV-specific antibodies during the COVID-19 pandemic , 2022, The Lancet Infectious Diseases.

[13]  A. Solimano,et al.  Comparative analysis of pediatric Respiratory Syncytial Virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada , 2022, medRxiv.

[14]  M. Savic,et al.  Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis , 2022, Influenza and other respiratory viruses.

[15]  T. Heikkinen,et al.  The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study , 2022, The Lancet. Respiratory medicine.

[16]  L. Peruzzi,et al.  How Covid-19 changed the epidemiology of febrile urinary tract infections in children in the emergency department during the first outbreak , 2022, BMC Pediatrics.

[17]  A. Elliot,et al.  Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study , 2022, The Lancet. Infectious diseases.

[18]  O. Ramilo,et al.  Respiratory syncytial virus and SARS‐CoV‐2 coinfections in children , 2022, Pediatric pulmonology.

[19]  T. De,et al.  Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study , 2022, PLoS medicine.

[20]  O. Ramilo,et al.  Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. , 2022, The Lancet. Infectious diseases.

[21]  O. Ramilo,et al.  Clinical Phenotype of Respiratory Syncytial Virus Bronchiolitis before and during the Coronavirus Disease 2019 Pandemic , 2022, American Journal of Perinatology.

[22]  Pengcheng Liu,et al.  Resurgence of Respiratory Syncytial Virus Infection During COVID-19 Pandemic Among Children in Shanghai, China , 2022, Frontiers in Microbiology.

[23]  C. Rodríguez‐Martínez,et al.  How did respiratory syncytial virus and other pediatric respiratory viruses change during the COVID‐19 pandemic? , 2022, Pediatric pulmonology.

[24]  P. Lavoie,et al.  Correlates of Protection Against Respiratory Syncytial Virus Infection in Infancy , 2022, Clinical Reviews in Allergy & Immunology.

[25]  Pengcheng Liu,et al.  The changing pattern of common respiratory and enteric viruses among outpatient children in Shanghai, China: Two years of the COVID‐19 pandemic , 2022, Journal of medical virology.

[26]  David J. Marchant,et al.  Waning immunity against respiratory syncytial virus during the COVID-19 pandemic , 2022, The Journal of infectious diseases.

[27]  S. Madhi,et al.  Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis , 2022, The Lancet.

[28]  A. Garbuglia,et al.  Changes in the Circulation of Common Respiratory Pathogens among Hospitalized Patients with Influenza-like Illnesses in the Lazio Region (Italy) during Fall Season of the Past Three Years , 2022, International journal of environmental research and public health.

[29]  J. Baillie,et al.  SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses , 2022, The Lancet.

[30]  R. Rothman,et al.  How COVID-19 impacted child and family health and healthcare: a mixed-methods study incorporating family voices , 2022, Translational behavioral medicine.

[31]  G. Boivin,et al.  Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells , 2022, Viruses.

[32]  G. Boivin,et al.  Viral Interference between Respiratory Viruses , 2022, Emerging infectious diseases.

[33]  H. Mostafa,et al.  Circulation of Non-SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic , 2021, Open forum infectious diseases.

[34]  A. Buja,et al.  Pediatric emergency department visits during the COVID-19 pandemic: a large retrospective population-based study , 2021, Italian Journal of Pediatrics.

[35]  V. Eapen,et al.  The impact of the COVID-19 pandemic on paediatric health service use within one year after the first pandemic outbreak in New South Wales Australia – a time series analysis , 2021, The Lancet Regional Health - Western Pacific.

[36]  H. Marshall,et al.  Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study , 2021, BMJ Open.

[37]  R. Beasley,et al.  Respiratory syncytial virus: paying the immunity debt with interest , 2021, The Lancet Child & Adolescent Health.

[38]  M. Kubo,et al.  SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism , 2021, Signal Transduction and Targeted Therapy.

[39]  S. W. Long,et al.  The Reemergence of Seasonal Respiratory Viruses in Houston, Texas, after Relaxing COVID-19 Restrictions , 2021, Microbiology spectrum.

[40]  S. Mukhi,et al.  Seasonality of Respiratory Viruses at Northern Latitudes , 2021, JAMA network open.

[41]  S. Tsuzuki,et al.  Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan , 2021, Emerging infectious diseases.

[42]  C. Delacourt,et al.  Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France , 2021, European Journal of Clinical Microbiology & Infectious Diseases.

[43]  S. Barry,et al.  Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection , 2021, BMC Medicine.

[44]  Wei Hao Lee,et al.  Examining the interseasonal resurgence of respiratory syncytial virus in Western Australia , 2021, Archives of Disease in Childhood.

[45]  J. Langley,et al.  Potential resurgence of respiratory syncytial virus in Canada , 2021, Canadian Medical Association Journal.

[46]  David W. Smith,et al.  Off-season RSV epidemics in Australia after easing of COVID-19 restrictions , 2021, Nature Communications.

[47]  L. Gagliardi,et al.  Delayed presentation of children to the emergency department during the first wave of COVID‐19 pandemic in Italy: Area‐based cohort study , 2021, Acta paediatrica.

[48]  S. de Lusignan,et al.  Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[49]  S. Kent,et al.  Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection , 2021, medRxiv.

[50]  D. Weinberger,et al.  Community factors associated with local epidemic timing of respiratory syncytial virus: A spatiotemporal modeling study , 2021, Science Advances.

[51]  R. Cohen,et al.  Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? , 2021, Infectious Diseases Now.

[52]  J. Adjemian,et al.  Changes in Seasonal Respiratory Illnesses in the United States During the COVID-19 Pandemic , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  Baoju Wang,et al.  Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment , 2021, mBio.

[54]  Daryl R. Cheng,et al.  Changing Epidemiology of Respiratory Syncytial Virus in Australia - delayed re-emergence in Victoria compared to WA/NSW after prolonged lock-down for COVID-19 , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  Y. Liao,et al.  Seasonal association between viral causes of hospitalised acute lower respiratory infections and meteorological factors in China: a retrospective study. , 2021, The Lancet. Planetary health.

[56]  R. Valenta,et al.  Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations , 2020, Allergy.

[57]  C. Sikazwe,et al.  The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  Kristine Macartney,et al.  COVID-19 public health measures and respiratory syncytial virus , 2020, The Lancet Child & Adolescent Health.

[59]  O. Kutsch,et al.  Sustained Cellular Immune Dysregulation in Individuals Recovering from SARS-CoV-2 Infection , 2020, medRxiv.

[60]  N. Bishop,et al.  Children's emergency presentations during the COVID-19 pandemic , 2020, The Lancet Child & Adolescent Health.

[61]  S. Ladhani,et al.  Delayed access to care and late presentations in children during the COVID-19 pandemic: a snapshot survey of 4075 paediatricians in the UK and Ireland , 2020, Archives of Disease in Childhood.

[62]  R. Isba,et al.  Where have all the children gone? Decreases in paediatric emergency department attendances at the start of the COVID-19 pandemic of 2020 , 2020, Archives of Disease in Childhood.

[63]  G. Trobia,et al.  Delayed access or provision of care in Italy resulting from fear of COVID-19 , 2020, The Lancet Child & Adolescent Health.

[64]  Rachel E. Baker,et al.  Epidemic dynamics of respiratory syncytial virus in current and future climates , 2019, Nature Communications.

[65]  S. Madhi,et al.  Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. , 2019, The Lancet. Global health.

[66]  R. Anderssen,et al.  Exploring the dynamics of respiratory syncytial virus (RSV) transmission in children. , 2016, Theoretical population biology.

[67]  I. Julkunen,et al.  Prospective clinical and serological follow-up in early childhood reveals a high rate of subclinical RSV infection and a relatively high reinfection rate within the first 3 years of life , 2016, Epidemiology and Infection.

[68]  S. Paynter.  Humidity and respiratory virus transmission in tropical and temperate settings , 2014, Epidemiology and Infection.

[69]  Graham F. Medley,et al.  The Source of Respiratory Syncytial Virus Infection In Infants: A Household Cohort Study In Rural Kenya , 2013, The Journal of infectious diseases.

[70]  F. Zhan,et al.  Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers. , 2013, The Journal of infectious diseases.

[71]  P. Openshaw,et al.  BRONCHIOLITIS , 2005, The Lancet.

[72]  OUP accepted manuscript , 2022, The Journal of Infectious Diseases.

[73]  OUP accepted manuscript , 2022, The Journal of Infectious Diseases.